Komori
Governance4523Eisai Co.,Ltd.Pharmaceuticals

Independent Officer Notification Form

The independent officer filing has been updated, with 8 outside directors reported as independent officers. Miura Ryota (三浦亮太) is scheduled to leave office upon expiration of his term, while Kawana Koichi (川名浩一) and Toyota Yuko (豊田祐子) are listed as newly appointed independent officers.

Worth reading
33Immaterial
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
8
People (independent officers)
Wording
Definitive
How definitive the wording is.

Governance structure

Company with Three Statutory Committees
Number of independent officers8Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Committee1
Nomination Committee
Changes this time

Miura Ryota (三浦亮太) is scheduled to leave office upon expiration of his term at the conclusion of the Annual General Meeting of Shareholders to be held on 17 June 2026. Kawana Koichi (川名浩一) and Toyota Yuko (豊田祐子) are listed as newly appointed independent officers. The independent officer filing has been updated.

Governance structure
ItemDetails
Corporate Governance StructureCompany with Three Statutory Committees
Number of independent officers8 independent officers
CommitteeNomination Committee (proportion of outside members: Not disclosed)
Changes this timeMiura Ryota (三浦亮太) is scheduled to leave office upon expiration of his term at the conclusion of the Annual General Meeting of Shareholders to be held on 17 June 2026. Kawana Koichi (川名浩一) and Toyota Yuko (豊田祐子) are listed as newly appointed independent officers. The independent officer filing has been updated.
Items this document does not state (4)
Number of directorsPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because a proposal to elect outside directors will be submitted to the Annual General Meeting of Shareholders. In addition, Miura Ryota (三浦亮太), who is currently designated as an independent officer, will leave office upon expiration of his term at the conclusion of the Annual General Meeting of Shareholders to be held on 17 June 2026.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Independent Officer Notification Form | Eisai Co.,Ltd. (4523) timely disclosure | Komori